A Philadelphia jury sent a strong message to Johnson & Johnson regarding the company's marketing of its prescription drug Risperdal. A Maryland man filed a lawsuit alleging that the company failed to properly acknowledge known risks that the prescription medication could lead to breast growth in boys.
A California jury awarded $40 million to a woman suffering from mesothelioma. The lawsuit against Johnson & Johnson alleged that the popular baby powder caused her mesothelioma diagnosis in 2017.
Johnson & Johnson, the manufacturer of popular talc baby powder has lost another case, this time in New York. Several lawsuits have been filed across the country alleging that Johnson & Johnson's talc-based baby powder causes certain cancers. Thus far, only a handful of cases have actually been tried to a jury.
A subsidiary of Johnson & Johnson, Ethicon, was hit with a $120 million verdict by a Pennsylvania jury. The lawsuit arose from medical mesh device which was implanted in the plaintiff during a 2008 procedure. The plaintiff, a 68-year-old woman, argued that she suffered from chronic pelvic pain and urinary tract infections as a result of the mesh. She was required to undergo a surgery to remove the mesh. Despite efforts by doctors, the surgery to remove the mesh was unsuccessful, her attorneys stated.
Johnson & Johnson lost a motion seeking to overturn a jury verdict in excess of $4 billion. The jury found that Johnson & Johnson was to blame for ovarian cancer of 22 women who sued the company. The cases centered around talc powder manufactured by Johnson & Johnson. The lawsuits allege that the company's baby powder and other talc powder products were contaminated with asbestos particles that can cause cancer.
A Missouri judge has recently upheld the award of 4.7 billion dollars in damages to twenty-two victims of ovarian cancer against Johnson & Johnson. This case stems from Johnson & Johnson having produced talc powder for decades, encouraging its use in women and children, all the while knowing of its contamination with asbestos. Company communications reveal both Johnson & Johnson's knowledge of the contamination, and of the health threats posed by asbestos. Citing the "reprehensible conduct" of the manufacturer, the judge upheld the judgment as being supported by the evidence adduced at trial.
Johnson & Johnson (JNJ) was ordered by a Texas jury to pay $1.2 million to a woman who alleged one of the company's lines of vaginal-mesh implants to treat incontinence was defectively designed, in the first verdict against the company over those devices. Jurors in Dallas determined the design of the TVT-O mesh sling implanted in Linda Batiste was flawed. The jury found $1.2 million in compensatory damages.
According to the New York Times, Johnson & Johnson has tentatively agreed to a settlement that could reach up to $4 billion to resolve thousands of lawsuits filed by patients injured by a flawed all-metal replacement hip implant.